Effect of nutrition on prognosis of Egyptian cirrhotic patients

Author(s): Engy Yousry Elsayed; Inas Elkhedr Mohamed*; Iman Mahmoud Ezzat

Abstract

Malnutrition is a common complication of end-stage liver disease, by far the easiest methods to differentiate compensated and uncompensated liver cirrhosis are the Child–Pugh and MELD score. These methods have omitted under nutrition from their scoring. Present study is aimed to study the effect of malnutrition among Egyptian cirrhotic patients on the prognosis and mortality. 300 Egyptian cirrhotic patients, laboratory and nutritional assessment were done according to RFH-SGA, measurement of BMI, TST, and MAMC. Each patient was assigned a Child and MELD score and all patients were followed up for six months. 49 patients (16.3%) died throughout the follow up. 57(19%) were severely malnourished. 134 (44.66%) and109 (36.33%) were well nourished and moderately malnourished, respectively. 63.4% of non-survivors were malnourished (p=0.001). A higher MELD score in non-survivors (29.8) than that of survivors (21.7) (P=0.007). Increase the TST (triceps skinfold thickness) in survivors (10.1mm i.e. less than 50th percentile) than in non-survivors (5.9mm i.e. less than 5th percentile) (P=0.003). The MAMC (midarm muscle circumference) was 24.5cm (i.e. 10th percentile) and 19.4cm (i.e. less than 5th percentile) in survivors and non-survivors, respectively (P=0.002). The nutritional status of cirrhotic patients is an important tool, together with MELD and Child score, to predict the prognosis of such patients and the severity of malnutrition is associated with higher mortality, early referral of cirrhotic patients with bad nutritional status for transplantation is recommended.

image 10.21746/ijbio.2015.11.0011

Share this article


International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.

International Journal of Bioassays [ISSN: International Journal of Bioassays] is licensed under
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Copyright 2012-2018. All rights reserved.